₹ 433.55
-15.45 (-3.44%)
C
Cohance Lifesciences
₹ 433.55
COHANCE Financials Summary (Consolidated)
Cohance Lifesciences revenue decreased 29.61% quarter-on-quarter to ₹435 Cr in Jun 2026, while net profit swung to a loss of ₹45 Cr from a profit of ₹8 Cr in the previous quarter. Compared to the same quarter last year, revenue is down 22.89% and net profit swung to a loss of ₹45 Cr from a profit of ₹46 Cr a year ago. EPS for the quarter stood at -₹0.63, decreased from ₹0.51 in the previous quarter and down from ₹1.28 a year ago.
Cohance Lifesciences Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of COHANCE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
COHANCE Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






